<?xml version="1.0" encoding="UTF-8"?>
<response>

<lst name="responseHeader">
  <int name="status">0</int>
  <int name="QTime">22</int>
  <lst name="params">
    <str name="echoParams">explicit</str>
    <str name="indent">true</str>
    <str name="file">data-lines/./reut2-017.sgm-679.txt</str>
    <str name="usePOS">true</str>
    <str name="sentences">3</str>
    <str name="wt">xml</str>
    <str name="formula">augNorm_inverse</str>
  </lst>
</lst>
<lst name="analysis">
  <lst name="summary">
    <lst name="stats">
      <lst name="sentences">
        <int name="count">35</int>
      </lst>
      <lst name="terms">
        <int name="count">111</int>
      </lst>
      <lst name="stems">
        <int name="count">63</int>
      </lst>
    </lst>
    <lst name="terms">
      <lst name="term">
        <str name="text">recommendation</str>
        <double name="strength">1.0</double>
      </lst>
      <lst name="term">
        <str name="text">consultant</str>
        <double name="strength">0.9999999999999989</double>
      </lst>
      <lst name="term">
        <str name="text">market</str>
        <double name="strength">0.9999999999999987</double>
      </lst>
      <lst name="term">
        <str name="text">beecham</str>
        <double name="strength">0.999999999999998</double>
      </lst>
      <lst name="term">
        <str name="text">patent</str>
        <double name="strength">0.9988798280552018</double>
      </lst>
    </lst>
    <lst name="sentences">
      <lst name="sentence">
        <str name="text">Last Friday, an advisory committee at the Food and Drug Administration, FDA, withheld a recommendation on Genentech's tissue plasminogen activator, a drug called Activase.</str>
        <int name="index">4</int>
        <int name="start">1</int>
        <int name="end">172</int>
        <double name="strength">1.0</double>
        <int name="terms">9</int>
      </lst>
      <lst name="sentence">
        <str name="text">"Genentech's advantage is being first in the market," said industry consultant Scott King, formerly an analyst with Montgomery Securities in San Francisco.</str>
        <int name="index">26</int>
        <int name="start">3</int>
        <int name="end">158</int>
        <double name="strength">0.9342305415285955</double>
        <int name="terms">10</int>
      </lst>
      <lst name="sentence">
        <str name="text">S. agency decision to withhold a recommendation on its genetically-produced drug which is used to treat heart attacks in progress, industry sources and analysts said.</str>
        <int name="index">1</int>
        <int name="start">0</int>
        <int name="end">166</int>
        <double name="strength">0.9237664534705728</double>
        <int name="terms">11</int>
      </lst>
    </lst>
    <lst name="highlighted">
      <lst name="sentence">
        <str name="text">Last &lt;em&gt;Friday,&lt;/em&gt; an &lt;em&gt;advisory committee&lt;/em&gt; at the Food and Drug &lt;em&gt;Administration,&lt;/em&gt; FDA, withheld a &lt;em&gt;recommendation&lt;/em&gt; on &lt;em&gt;Genentech&lt;/em&gt;'s &lt;em&gt;tissue plasminogen&lt;/em&gt; activator, a drug called &lt;em&gt;Activase&lt;/em&gt;.</str>
        <int name="index">4</int>
      </lst>
      <lst name="sentence">
        <str name="text">&lt;em&gt;"Genentech&lt;/em&gt;'s &lt;em&gt;advantage&lt;/em&gt; is being first in the &lt;em&gt;market,"&lt;/em&gt; said &lt;em&gt;industry consultant Scott&lt;/em&gt; King, formerly an &lt;em&gt;analyst&lt;/em&gt; with &lt;em&gt;Montgomery Securities&lt;/em&gt; in San &lt;em&gt;Francisco&lt;/em&gt;.</str>
        <int name="index">26</int>
      </lst>
      <lst name="sentence">
        <str name="text">S. &lt;em&gt;agency decision&lt;/em&gt; to &lt;em&gt;withhold&lt;/em&gt; a &lt;em&gt;recommendation&lt;/em&gt; on its genetically-produced drug which is used to &lt;em&gt;treat heart attacks&lt;/em&gt; in &lt;em&gt;progress, industry sources&lt;/em&gt; and &lt;em&gt;analysts said&lt;/em&gt;.</str>
        <int name="index">1</int>
      </lst>
    </lst>
  </lst>
</lst>
</response>
